Introduction: Both microenvironmental signals from surrounding cells and changes in the genome of leukemic cells play essential role in the development of chronic lymphocytic leukemia. Nurse-like cells (NLCs) are one of the important elements of the microenvironment of CLL cells. The key role in the interactions of leukemic cells with NLCs is played by chemokines, which may interfere with the programmed cell death process in the leukemic lymphocytes. The aim of our study was analysis of selected microenvironmental factors having a potential impact on the leukemic cells survival, as well as their association with clinical, cytogenetic, and molecular parameters. For this study, we selected three types of molecules which can modulate microenvironment: chemokines IL-8 and CCL3 (which are classically secreted to extracellular matrix), soluble forms of adhesion molecules JAG1 and CD163, and secreted form of endogenous protein BIRC5. We assessed their expression in the serum of CLL patients as well as in medium of long-term NLCs cultures. Methods: Long-term cell culture was prepared from mononuclear cells derived from the blood of 34 patients with CLL. Number of NLCs cells was evaluated, under a light inverted microscope. The concentration of IL-8, CCL3, sBIRC5, sCD163, and sJAG1 in culture medium and serum was assessed by enzyme-linked immunosorbent assays. Results: There were significant differences in the concentration of IL-8, sBIRC5, CCL3, sCD163, and sJAG1 between the patient’s blood serum and the culture medium. The concentrations of IL-8, CCL3, and JAG1 were higher in the culture medium, which confirmed the role of the microenvironment in the production of these proteins. In addition, the concentration of CCL3 chemokine in both patient’s blood serum and in the culture medium correlated with the number of NLCs and with known prognostic factors in the course of CLL, e.g., Rai stage, WBC, expression of ZAP-70, CD38, and CD5/19. Conclusion: The microenvironment of CLL cells, which includes NLCs, plays an important role in the pathogenesis of CLL. The CCL3 chemokine seems to be a good factor representing microenvironment of CLL cells. Chronic lymphocytic leukemia is a complex and very heterogeneous disease; therefore, its progress should be considered both in the context of genetic changes and the interaction with microenvironmental cells.

1.
Scarfò
L
,
Ferreri
AJM
,
Ghia
P
.
Chronic lymphocytic leukaemia
.
Crit Rev Oncol Hemat
.
2016 Aug
104
169
82
.
2.
Döhner
H
,
Stilgenbauer
S
,
Benner
A
,
Leupolt
E
,
Krober
A
,
Bullinger
L
.
Genomic aberrations and survival in chronic lymphocytic leukemia
.
N Engl J Med
.
2000 Dec 28
343
26
1910
6
.
3.
Malcikova
J
,
Tausch
E
,
Rossi
D
,
Sutton
LA
,
Soussi
T
,
Zenz
T
.
ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-update on methodological approaches and results interpretation
.
Leukemia
.
2018 May
32
5
1070
80
.
4.
Tsukada
N
,
Burger
JA
,
Zvaifler
NJ
,
Kipps
T
.
Distinctive features of “nurselike” cells that differentiate in the context of chronic lymphocytic leukemia
.
Blood
.
2002 Feb 1
99
3
1030
7
.
5.
Ponzoni
M
,
Doglioni
C
,
Caligaris-Cappio
F
.
Chronic lymphocytic leukemia: the pathologist’s view of lymph node microenvironment
.
Semin Diagn Pathol
.
2011 May
28
2
161
6
.
6.
Burger
JA
.
The CLL cell microenvironment
.
Adv Exp Med Biol
.
2013
;
792
:
25
45
.
7.
Burger
JA
,
Tsukada
N
,
Burger
M
,
Zvaifler
NJ
,
Dell’Aquila
M
,
Kipps
TJ
.
Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1
.
Blood
.
2000 Oct 15
96
8
2655
63
.
8.
Filip
AA
,
Ciseł
B
,
Koczkodaj
D
,
Wąsik-Szczepanek
E
,
Piersiak
T
,
Dmoszyńska
A
.
Circulating microenvironment of CLL: are nurse-like cells related to tumor-associated magrophages
.
Blood Cell Mol Dis
.
2013 Apr
50
4
263
70
.
9.
Burger
JA
,
Quiroga
MP
,
Hartmann
E
,
Bürkle
A
,
Wierda
WG
,
Keating
MJ
.
High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia B cells in nurselike cell cocultures and after BCR stimulation
.
Blood
.
2009 Mar 26
113
13
3050
8
.
10.
Ysebaert
L
,
Fournié
JJ
.
Genomic and phenotypic characterization of nurse-like cells that promote drug resistance in chronic lymphocytic leukemia
.
Leuk Lymphoma
.
2011
;
52
(
7
):
1404
6
.
11.
Di Celle
PF
,
Carbone
A
,
Marchis
D
,
Zhou
D
,
Sozzani
S
,
Zupo
S
.
Cytokine gene expression in B-cell chronic lymphocytic leukemia: evidence of constitutive interleukin-8 (IL-8) mRNA expression and secretion of biologically active IL-8 protein
.
Blood
.
1994 Jul 1
84
1
220
8
.
12.
Sivina
M
,
Hartmann
E
,
Kipps
TJ
,
Rassenti
L
,
Krupnik
D
,
Lerner
S
.
CCL3 (MIP-1α) plasma levels and the risk for disease progression in chronic lymphocytic leukemia
.
Boold
.
2011 Feb 3
117
5
1662
9
.
13.
ten Hacken
E
,
Burger
JA
.
Microenvironment dependency in chronic lymphocytic leukemia: the basis for new targeted therapies
.
Pharmacol Ther
.
2014 Dec
144
3
338
48
.
14.
Hartmann
EM
,
Rudelius
M
,
Burger
JA
,
Rosenwald
A
.
CCL3 chemokine expression by chronic lymphocytic leukemia cells orchestrates the composition of the microenvironment in lymph node infiltrates
.
Leuk Lymphoma
.
2016
;
57
(
3
):
563
71
.
15.
Wierda
W
,
Johnson
MM
,
Do
K
,
Manshouri
T
,
Dey
A
,
O’Brien
S
.
Plasma interleukin 8 level predicts for survival in chronic lymphocytic leukaemia
.
Br J Haematol
.
2003 Feb
120
3
452
6
.
16.
Moller
HJ
.
Soluble CD163
.
Scand J Clin Lab Inv
.
2012 Feb
72
1
1
13
.
17.
Nederby
L
,
Roug
A
,
Knudsen
S
,
Moller
HJ
,
Skovbo
A
,
Hokland
M
.
Relevance of sCD163 as a prognostic biomarker in chronic B-cell lymphocytic leukemia
.
Blood
.
2014 Dec
124
21
5643
.
18.
Rosati
E
,
Sabatini
R
,
Rampino
G
,
Tabilio
A
,
Di Ianni
M
,
Fettucciari
K
.
Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells
.
Blood
.
2009 Jan
113
4
856
65
.
19.
Necochea-Campion
R
,
Chen
CS
,
Mirshahidi
S
,
Howard
FD
,
Wall
NR
.
Clinico-pathologic relevance of survivin splice variant expression in cancer
.
Cancer Lett
.
2013 Oct
339
2
167
74
.
20.
Khan
S
,
Bennit
HF
,
Turay
D
,
Perez
M
,
Mirshahidi
S
,
Yuan
Y
.
Early diagnostic value of survivin and its alternative splice variants in breast cancer
.
BMC Cancer
.
2014 Mar 12
14
176
.
21.
Filip
AA
,
Ciseł
B
,
Wąsik-Szczepanek
E
.
Guilty bystanders: nurse-like cells as a model of microenvironmental support for leukemic lymphocytes
.
Clin Exp Med
.
2015 Feb
15
1
73
83
.
22.
Hallek
M
,
Cheson
BD
,
Catovsky
D
,
Caligaris-Cappio
F
,
Dighiero
G
,
Döhner
H
.
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
.
Blood
.
2018 Jun 21
131
25
2745
60
.
23.
Stamatopoulos
K
,
Agathangelidis
A
,
Rosenquist
R
,
Ghia
P
.
Antigen receptor stereotypy in chronic lymphocytic leukemia
.
Leukemia
.
2017 Feb
31
2
282
91
.
24.
Huang
SJ
,
Gillan
TL
,
Gerrie
AS
,
Hrynchak
M
,
Karsan
A
,
Ramadan
K
.
Influence of clone and deletion size on outcome in chronic lymphocytic leukemia patients with an isolated deletion 13q in a population-based analysis in British Columbia, Canada
.
Genes Chromosomes Cancer
.
2016 Jan
55
1
16
24
.
25.
Dal Bo
M
,
Rossi
FM
,
Rossi
D
,
Deambrogi
C
,
Bertoni
F
,
Del Giudice
I
.
13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia
.
Genes Chromosomes Cancer
.
2011 Aug
50
8
633
43
.
26.
Matthews
C
,
Catherwood
M
,
Morris
TC
,
Alexander
HD
.
Routine analysis of IgVH mutational status in CLL patients using BIOMED-2 standarized primers and protocols
.
Leuk Lymphoma
.
2004 Sep
45
9
1899
904
.
27.
Mansour
MR
,
Duke
V
,
Foroni
L
,
Patel
B
,
Allen
CG
,
Ancliff
PJ
.
Notch-1 mutations are secondary events in some patients with T-cell acute lymphoblastic leukemia
.
Clin Cancer Res
.
2007 Dec 1
13
23
6964
9
.
28.
Fabbri
G
,
Rasi
S
,
Rossi
D
,
Trifonov
V
,
Khiabanian
H
,
Ma
J
.
Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation
.
J Exp Med
.
2011 Jul 4
208
7
1389
401
.
29.
Puente
XS
,
Pinyol
M
,
Quesada
V
,
Conde
L
,
Ordóñez
GR
,
Villamor
N
.
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
.
Nature
.
2011 Jun 5
475
7354
101
5
.
30.
Landau
DA
,
Carter
SL
,
Stojanov
P
,
McKenna
A
,
Stevenson
K
,
Lawrence
MS
.
Evolution and impact of subclonal mutations in chronic lymphocytic leukemia
.
Cell
.
2013 Feb 14
152
4
714
26
.
31.
Trimarco
V
,
Ave
E
,
Facco
M
,
Chiodin
G
,
Frezzato
F
,
Martini
V
.
Cross-talk between chronic lymphocytic leukemia (CLL) tumor B cells and mesenchymal stromal cells (MSCs): implications for neoplastic cell survival
.
Oncotarget
.
2015 Dec 8
6
39
42130
49
.
32.
Jaiswal
PK
,
Goel
A
,
Mittal
RD
.
Survivin: a molecular biomarker in cancer
.
Indian J Med Res
.
2015 Apr
141
4
389
97
.
33.
Shinohara
ET
,
Gonzalez
A
,
Massion
PP
,
Chen
H
,
Li
M
,
Freyer
AS
.
Nuclear survivin predicts recurrence and poor survival in patients with resected nonsmall cell lung carcinoma
.
Cancer
.
2005 Apr 15
103
8
1685
92
.
34.
Granziero
L
,
Ghia
P
,
Circosta
P
,
Gottardi
D
,
Strola
G
,
Geuna
M
.
Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia
.
Blood
.
2001 May 1
97
9
2777
83
.
35.
Purroy
N
,
Abrisqueta
P
,
Carabia
J
,
Carpio
C
,
Calpe
E
,
Palacio
C
.
Targeting the proliferative and chemoresistant compartment in chronic lymphocytic leukemia by inhibiting survivin protein
.
Leukemia
.
2014 Oct
28
10
1993
2004
.
36.
Ahmed
MB
,
Shehata
HH
,
Moussa
M
,
Ibrahim
TM
.
Prognostic significance of survivin and tumor necrosis factor-alpha in adult acute lymphoblastic leukemia
.
Clin Biochem
.
2012 Jan
45
1–2
112
6
.
37.
Risnik
D
,
Podaza
E
,
Almejún
MB
,
Colado
A
,
Elías
EE
,
Bezares
RF
.
Revisiting the role of interleukin-8 in chronic lymphocytic leukemia
.
Sci Rep
.
2017
;
7
(
1
):
15714
.
38.
Yoon
JY
,
Lafarge
S
,
Dawe
D
,
Lakhi
S
,
Kumar
R
,
Morales
C
.
Association of interleukin-6 and interleukin-8 with poor prognosis in elderly patients with chronic lymphocytic leukemia
.
Leuk Lymphoma
.
2012 Sep
53
9
1735
42
.
39.
Arruga
F
,
Gizdic
B
,
Serra
S
,
Vaisitti
T
,
Ciardullo
C
,
Coscia
M
.
Functional impact of NOTCH1 mutations in chronic lymphocytic leukemia
.
Leukemia
.
2014 May
28
5
1060
70
.
40.
Boissard
F
,
Laurent
C
,
Ramsay
AG
,
Quillet-Mary
A
,
Fournié
JJ
,
Poupot
M
.
Nurse-like cells impact on disease progression in chronic lymphocytic leukemia
.
Blood Cancer J
.
2016 Jan 15
6
1
e381
.
You do not currently have access to this content.